GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.lungcan.2020.07.022
dc.identifier.other
WOS:000573480700007
dc.description.volume
dc.description.issue
Publisher
ELSEVIER IRELAND LTD
DOI
10.1016/j.lungcan.2020.07.022
